Search Results - "PASQUINI, C"

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes by Scott, Bart L, Pasquini, Marcelo C, Logan, Brent R, Wu, Juan, Devine, Steven M, Porter, David L, Maziarz, Richard T, Warlick, Erica D, Fernandez, Hugo F, Alyea, Edwin P, Hamadani, Mehdi, Bashey, Asad, Giralt, Sergio, Geller, Nancy L, Leifer, Eric, Le-Rademacher, Jennifer, Mendizabal, Adam M, Horowitz, Mary M, Deeg, H Joachim, Horwitz, Mitchell E

“…Purpose The optimal regimen intensity before allogeneic hematopoietic cell transplantation (HCT) is unknown. We hypothesized that lower treatment-related…”
Get full text

Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial by Stadtmauer, Edward A, Pasquini, Marcelo C, Blackwell, Beth, Hari, Parameswaran, Bashey, Asad, Devine, Steven, Efebera, Yvonne, Ganguly, Siddharta, Gasparetto, Cristina, Geller, Nancy, Horowitz, Mary M, Koreth, John, Knust, Kristin, Landau, Heather, Brunstein, Claudio, McCarthy, Philip, Nelson, Courtney, Qazilbash, Muzaffar H, Shah, Nina, Vesole, David H, Vij, Ravi, Vogl, Dan T, Giralt, Sergio, Somlo, George, Krishnan, Amrita

“…Single-cycle melphalan 200 mg/m and autologous hematopoietic cell transplantation (AHCT) followed by lenalidomide (len) maintenance have improved…”
Get full text

Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey by Niederwieser, D, Baldomero, H, Szer, J, Gratwohl, M, Aljurf, M, Atsuta, Y, Bouzas, L F, Confer, D, Greinix, H, Horowitz, M, Iida, M, Lipton, J, Mohty, M, Novitzky, N, Nunez, J, Passweg, J, Pasquini, M C, Kodera, Y, Apperley, J, Seber, A, Gratwohl, A

“…Data on 68 146 hematopoietic stem cell transplants (HSCTs) (53% autologous and 47% allogeneic) gathered by 1566 teams from 77 countries and reported through…”
Get full text

Plant responses to fertilization experiments in lowland, species-rich, tropical forests by Joseph Wright, S., Turner, Benjamin L., Yavitt, Joseph B., Harms, Kyle E., Kaspari, Michael, Tanner, Edmund V. J., Bujan, Jelena, Griffin, Eric A., Mayor, Jordan R., Pasquini, Sarah C., Sheldrake, Merlin, Garcia, Milton N.

“…We present a meta-analysis of plant responses to fertilization experiments conducted in lowland, species-rich, tropical forests. We also update a key result…”
Get full text

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma by Pasquini, Marcelo C., Hu, Zhen-Huan, Curran, Kevin, Laetsch, Theodore, Locke, Frederick, Rouce, Rayne, Pulsipher, Michael A., Phillips, Christine L., Keating, Amy, Frigault, Matthew J., Salzberg, Dana, Jaglowski, Samantha, Sasine, Joshua P., Rosenthal, Joseph, Ghosh, Monalisa, Landsburg, Daniel, Margossian, Steven, Martin, Paul L., Kamdar, Manali K., Hematti, Peiman, Nikiforow, Sarah, Turtle, Cameron, Perales, Miguel-Angel, Steinert, Patricia, Horowitz, Mary M., Moskop, Amy, Pacaud, Lida, Yi, Lan, Chawla, Raghav, Bleickardt, Eric, Grupp, Stephan

“…Tisagenlecleucel is a CD19 chimeric antigen receptor (CAR) T-cell therapy approved for treatment of pediatric and young adult patients with relapsed/refractory…”
Get full text

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study by Gratwohl, Alois, Baldomero, Helen, Gratwohl, Michael, Aljurf, Mahmoud, Bouzas, Luis Fernando, Horowitz, Mary, Kodera, Yoshihisa, Lipton, Jeff, Iida, Minako, Pasquini, Marcelo C, Passweg, Jakob, Szer, Jeff, Madrigal, Alejandro, Frauendorfer, Karl, Niederwieser, Dietger

“…Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined…”
Get full text

Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR by Sureda, Anna, Zhang, Mei‐Jie, Dreger, Peter, Carreras, Jeanette, Fenske, Timothy, Finel, Herve, Schouten, Harry, Montoto, Silvia, Robinson, Stephen, Smith, Sonali M., Boumedil, Ariane, Hamadani, Mehdi, Pasquini, Marcelo C.

“…BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo‐HCT) remains the only potentially curative treatment option for relapsed follicular…”
Get full text

Nutrients limit photosynthesis in seedlings of a lowland tropical forest tree species by Pasquini, S. C., Santiago, L. S.

“…We investigated how photosynthesis by understory seedlings of the lowland tropical tree species Alseis blackiana responded to 10 years of soil nutrient…”
Get full text

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies by Olsson, R F, Logan, B R, Chaudhury, S, Zhu, X, Akpek, G, Bolwell, B J, Bredeson, C N, Dvorak, C C, Gupta, V, Ho, V T, Lazarus, H M, Marks, D I, Ringdén, O T H, Pasquini, M C, Schriber, J R, Cooke, K R

“…Clinical outcomes after primary graft failure (PGF) remain poor. Here we present a large retrospective analysis ( n =23 272) which investigates means to…”
Get full text

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation by PASQUINI, Marcelo C, DEVINE, Steven, O'REILLY, Richard J, SOIFFER, Robert J, MENDIZABAL, Adam, BADEN, Lindsey R, WINGARD, John R, LAZARUS, Hillard M, APPELBAUM, Frederick R, KEEVER-TAYLOR, Carolyn A, HOROWITZ, Mary M, CARTER, Shelly

“…T-cell depletion (TCD) reduces the incidence of graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT). However, concerns about…”
Get full text

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation by Bredeson, Christopher, LeRademacher, Jennifer, Kato, Kazunobu, DiPersio, John F., Agura, Edward, Devine, Steven M., Appelbaum, Frederick R., Tomblyn, Marcie R., Laport, Ginna G., Zhu, Xiaochun, McCarthy, Philip L., Ho, Vincent T., Cooke, Kenneth R., Armstrong, Elizabeth, Smith, Angela, Rizzo, J. Douglas, Burkart, Jeanne M., Pasquini, Marcelo C.

“…We conducted a prospective cohort study testing the noninferiority of survival of ablative intravenous busulfan (IV-BU) vs ablative total body irradiation…”
Get full text

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States by D'Souza, Anita, Fretham, Caitrin, Lee, Stephanie J, Arora, Mukta, Brunner, Janet, Chhabra, Saurabh, Devine, Steven, Eapen, Mary, Hamadani, Mehdi, Hari, Parameswaran, Pasquini, Marcelo C, Perez, Waleska, Phelan, Rachel A, Riches, Marcie L, Rizzo, J Douglas, Saber, Wael, Shaw, Bronwen E, Spellman, Stephen R, Steinert, Patricia, Weisdorf, Daniel J, Horowitz, Mary M

“…•We summarize hematopoietic cell transplantation activity in the United States in 2018.•Key findings include fewer autologous transplantations performed for…”
Get full text

The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes by Artz, Andrew S, Logan, Brent, Zhu, Xiaochun, Akpek, Gorgun, Bufarull, Rodrigo Martino, Gupta, Vikas, Lazarus, Hillard M, Litzow, Mark, Loren, Alison, Majhail, Navneet S, Maziarz, Richard T, McCarthy, Philip, Popat, Uday, Saber, Wael, Spellman, Stephen, Ringden, Olle, Wickrema, Amittha, Pasquini, Marcelo C, Cooke, Kenneth R

“…We sought to confirm the prognostic importance of simple clinically available biomarkers of C-reactive protein, serum albumin, and ferritin prior to allogeneic…”
Get full text

Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102): a phase 3 biological assignment trial by Krishnan, Amrita, MD, Pasquini, Marcelo C, MD, Logan, Brent, PhD, Stadtmauer, Edward A, Prof, Vesole, David H, Prof, Alyea, Edwin, MD, Antin, Joseph H, Prof, Comenzo, Raymond, Prof, Goodman, Stacey, Prof, Hari, Parameswaran, MD, Laport, Ginna, MD, Qazilbash, Muzaffar H, MD, Rowley, Scott, Prof, Sahebi, Firoozeh, MD, Somlo, George, MD, Vogl, Dan T, MD, Weisdorf, Daniel, Prof, Ewell, Marian, ScD, Wu, Juan, MS, Geller, Nancy L, PhD, Horowitz, Mary M, MD, Giralt, Sergio, Prof, Maloney, David G, Prof

“…Summary Background Autologous haemopoietic stem-cell transplantation (HSCT) improves survival in patients with multiple myeloma, but disease progression…”
Get full text

Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes—Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial by Scott, Bart L., Pasquini, Marcelo C., Fei, Mingwei, Fraser, Raphael, Wu, Juan, Devine, Steve M., Porter, David L., Maziarz, Richard T., Warlick, Erica, Fernandez, Hugo F., Soiffer, Robert J., Alyea, Edwin, Hamadani, Mehdi, Bashey, Asad, Giralt, Sergio, Geller, Nancy L., Leifer, Eric, Hourigan, Christopher S., Gui, Gege, Mendizabal, Adam, Horowitz, Mary M., Deeg, H. Joachim, Horwitz, Mitchell E.

“…•There was a higher rate of treatment-related mortality with myeloablative conditioning, but this was offset by a much higher rate of relapse with…”
Get full text

One million haemopoietic stem-cell transplants: a retrospective observational study by Gratwohl, Alois, Prof, Pasquini, Marcelo C, MD, Aljurf, Mahmoud, Prof, Atsuta, Yoshiko, MD, Baldomero, Helen, BMS, Foeken, Lydia, MD, Gratwohl, Michael, PhD, Bouzas, Luis Fernando, Prof, Confer, Dennis, MD, Frauendorfer, Karl, PhD, Gluckman, Eliane, Prof, Greinix, Hildegard, Prof, Horowitz, Mary, Prof, Iida, Minako, MD, Lipton, Jeff, Prof, Madrigal, Alejandro, MD, Mohty, Mohamad, Prof, Noel, Luc, MD, Novitzky, Nicolas, Prof, Nunez, José, MD, Oudshoorn, Machteld, PhD, Passweg, Jakob, Prof, van Rood, Jon, Prof, Szer, Jeff, Prof, Blume, Karl, Prof, Appelbaum, Frederic R, Prof, Kodera, Yoshihisa, Prof, Niederwieser, Dietger, Prof

“…Summary Background The transplantation of cells, tissues, and organs has been recognised by WHO as an important medical task for its member states; however,…”
Get full text

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made? by HORAN, John T, LOGAN, Brent R, KHOURY, Hanna Jean, JUCKETT, Mark B, LITZOW, Mark R, MARTINO, Rodrigo, MCCARTHY, Philip L, SMITH, Franklin O, RIZZO, J. Douglas, PASQUINI, Marcelo C, AGOVI-JOHNSON, Manza-A, LAZARUS, Hillard M, BACIGALUPO, Andrea A, BALLEN, Karen K, BREDESON, Christopher N, CARABASI, Matthew H, GUPTA, Vikas, HALE, Gregory A

“…Transplantation-related mortality (TRM) is a major barrier to the success of allogeneic hematopoietic cell transplantation (HCT). We assessed changes in the…”
Get full text

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia by Litzow, Mark R., Tarima, Sergey, Pérez, Waleska S., Bolwell, Brian J., Cairo, Mitchell S., Camitta, Bruce M., Cutler, Corey S., de Lima, Marcos, DiPersio, John F., Gale, Robert Peter, Keating, Armand, Lazarus, Hillard M., Luger, Selina, Marks, David I., Maziarz, Richard T., McCarthy, Philip L., Pasquini, Marcelo C., Phillips, Gordon L., Rizzo, J. Douglas, Sierra, Jorge, Tallman, Martin S., Weisdorf, Daniel J.

“…Therapy-related myelodysplastic syndromes (t-MDSs) and acute myeloid leukemia (t-AML) have a poor prognosis with conventional therapy. Encouraging results are…”
Get full text

Effects of spleen status on early outcomes after hematopoietic cell transplantation by Akpek, G, Pasquini, M C, Logan, B, Agovi, M-A, Lazarus, H M, Marks, D I, Bornhaeüser, M, Ringdén, O, Maziarz, R T, Gupta, V, Popat, U, Maharaj, D, Bolwell, B J, Rizzo, J D, Ballen, K K, Cooke, K R, McCarthy, P L, Ho, V T

“…To assess the impact of spleen status on engraftment, and early morbidity and mortality after allogeneic hematopoietic cell transplantation (HCT), we analyzed…”
Get full text

Five hematologic tests and treatments to question by Hicks, Lisa K., Bering, Harriet, Carson, Kenneth R., Haynes, Adam E., Kleinerman, Judith, Kukreti, Vishal, Ma, Alice, Mueller, Brigitta U., O’Brien, Sarah H., Panepinto, Julie A., Pasquini, Marcelo C., Rajasekhar, Anita, Sarode, Ravi, Wood, William A.

“…Choosing Wisely® is a medical stewardship initiative led by the American Board of Internal Medicine Foundation in collaboration with professional medical…”
Get full text